Daprica M Forte 5/10
Composition
Description
Dapagliflozin is an inhibitor of SGLT2. They inhibit reabsorption of glucose (70 to 80 gm per day) in the kidney and therefore lower blood sugar by inhibiting sodium-glucose transport protein 2 (SGLT2). Dapagliflozin also reduces sodium reabsorption and increases the delivery of sodium to the distal tubule. Metformin decreases hepatic glucose production, decreases intestinal absorption of glucose, and improves insulin sensitivity by increasing peripheral glucose uptake and utilization.
Daprica M 5/10
Composition
Description
Dapagliflozin is an inhibitor of SGLT2. They inhibit reabsorption of glucose (70 to 80 gm per day) in the kidney and therefore lower blood sugar by inhibiting sodium-glucose transport protein 2 (SGLT2). Dapagliflozin also reduces sodium reabsorption and increases the delivery of sodium to the distal tubule. Metformin decreases hepatic glucose production, decreases intestinal absorption of glucose, and improves insulin sensitivity by increasing peripheral glucose uptake and utilization.
Daprica 5/10
Composition
Dapagliflozin 5mg/10mg Tablets
Description
A class of medications that alter essential physiology of the nephron. They inhibit the reabsorption of glucose (70 to 80 gm per day) in the kidney and therefore lower blood sugar by inhibiting sodium-glucose transport protein 2 (SGLT2). Apart from blood sugar control, gliflozins have been shown to provide additional benefits like - Cardiovascular benefits - Renoprotection - Pleiotropic effects